Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC)

Autor: Marcia M L Kho, A Lianne Messchendorp, Sophie C Frölke, Celine Imhof, Vera JCH Koomen, S Reshwan K Malahe, Priya Vart, Daryl Geers, Rory D de Vries, Corine H GeurtsvanKessel, Carla C Baan, Renate G van der Molen, Dimitri A Diavatopoulos, Ester B M Remmerswaal, Debbie van Baarle, Rob van Binnendijk, Gerco den Hartog, Aiko P J de Vries, Ron T Gansevoort, Frederike J Bemelman, Marlies E J Reinders, Jan-Stephan F Sanders, Luuk B Hilbrands, Alferso C. Abrahams, Marije C. Baas, Pim Bouwmans, Marc A.G.J. ten Dam, Lennert Gommers, Dorien Standaar, Marieke van der Heiden, Yvonne M.R. Adema, Marieken J. Boer-Verschragen, Wouter B. Mattheussens, Ria H.L.A. Philipsen, Djenolan van Mourik, Susanne Bogers, Laura L.A. van Dijk, Nynke Rots, Gaby Smits, Marjan Kuijer, Marc H. Hemmelder

Publikováno v: Lancet Infectious Diseases, 23, 307-319
Lancet infectious diseases, 23(3), 307-319. Lancet Publishing Group
Lancet Infectious Diseases, 23(3), 307-319. ELSEVIER SCI LTD
The Lancet Infectious Diseases, 23(3), 307-319. Lancet Publishing Group
Lancet Infectious Diseases, 23, 3, pp. 307-319

BACKGROUND: An urgent need exists to improve the suboptimal COVID-19 vaccine response in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with a control single dose mRNA-1273 vaccination: a double vaccine dose, he

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e83aaaad3fb6c01d134e2f61f346dd
https://pure.eur.nl/en/publications/7c01b0ca-5480-4d2b-acfb-2834cc7589ba

Divergent SARS CoV-2 Omicron-specific T- and B-cell responses in COVID-19 vaccine recipients

Autor: Corine H. GeurtsvanKessel, Daryl Geers, Katharina S. Schmitz, Anna Z. Mykytyn, Mart M Lamers, Susanne Bogers, Lennert Gommers, Roos S.G. Sablerolles, Nella N. Nieuwkoop, Laurine C. Rijsbergen, Laura L.A. van Dijk, Janet de Wilde, Kimberley Alblas, Tim I. Breugem, Bart J.A. Rijnders, Herbert de Jager, Daniela Weiskopf, P. Hugo M. van der Kuy, Alessandro Sette, Marion P.G. Koopmans, Alba Grifoni, Bart L. Haagmans, Rory D. de Vries

The severe acute respiratory distress syndrome coronavirus-2 (SARS-CoV-2) Omicron variant (B.1.1.529) is spreading rapidly, even in vaccinated individuals, raising concerns about immune escape. Here, we studied neutralizing antibodies and T-cell resp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5602d9b9148166862b90a0f844d96086
https://doi.org/10.1101/2021.12.27.21268416

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.